Isaxonine Phosphate

CHEMBL1697751 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
235.2 g/mol
LogP
Phase
4

A phosphate salt form of isaxonine, a peripheral nerve regeneration agent investigated for treating neuropathies. It was withdrawn from the market due to serious liver toxicity.

Khối lượng phân tử

235,1800 g/mol

TPSA

116,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)Nc1ncccn1.O=P(O)(O)O

InChI

InChI=1S/C7H11N3.H3O4P/c1-6(2)10-7-8-4-3-5-9-7;1-5(2,3)4/h3-6H,1-2H3,(H,8,9,10);(H3,1,2,3,4)

Molecular Formula

C7H14N3O4P

HBD / HBA

4 / 7

Liên kết có thể quay

2

Nguyên tử nặng

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A phosphate salt form of isaxonine, a peripheral nerve regeneration agent investigated for treating neuropathies. It was withdrawn from the market due to serious liver toxicity.

Yes, Isaxonine Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1697751. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 163093. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.